Pfizer shares rose 0.5% in premarket trading on Tuesday after the company reported first-quarter earnings and revenue that topped expectations. Pfizer also kept its full-year outlook unchanged, giving investors some reassurance as the company faces a tough period of patent expirations through the end of the decade.
Pfizer reported adjusted earnings of 75 cents per share, beating the analyst estimate of 72 cents. Revenue for the quarter reached $14.5 billion, above the $13.8 billion expected by Wall Street. The chief financial officer pointed to 22% operational revenue growth, thanks to new and acquired products. This suggests Pfizer’s efforts to expand its portfolio are starting to pay off.
Pfizer kept its full-year forecast for adjusted earnings at $2.80 to $3.00 per share and revenue between $59.5 billion and $62.5 billion, which matches what analysts expected. Management also said the outlook does not factor in any share buybacks in 2026.
This steady outlook comes as Pfizer faces a major period of patent expirations, with protections on important drugs like Eliquis ending before the decade is over. To address this, Pfizer is both working with generic drug makers to extend patents for some products, such as Vyndaqel, and expanding its pipeline through acquisitions and in-house development to make up for expected revenue losses from new competition.
Featured CoursesRecent news
Spotify Stock Surges 15% on Long-Term Growth Targets and New Premium Features
Spotify shares had their best day in almost seven years, climbing 15% on Thursday. The jump came after the company’s investor day, where Spotify shared long-term revenue and margin goals to give investors a clearer picture of its plans. These specific commitments sparked new interest in the stock after a stretch of weaker performance. Co-CEOs […]
Nebius Stock Jumps 7.8% on $2.6B Bloom Energy Power Deal for AI Data Centers.
Nebius Group shares rose 7.8% in premarket trading after the AI cloud provider announced a $2.6 billion deal with Bloom Energy to supply fuel-cell power for its data centers. This move tackles a major challenge in building AI infrastructure. The deal also highlights the growing power crisis for neocloud operators and explains why Bloom Energy […]
SpaceX IPO Opens to Retail Investors Through Robinhood, Fidelity, and Schwab
SpaceX has announced that some shares will be available through Robinhood, Fidelity, and Charles Schwab. This means everyday traders can access the IPO at the same price and time as big institutional buyers. Here’s what this means for retail investors and why it’s important to pay attention to the details. This approach is different from […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.